Work

Rapid Enhancement of Glutamatergic Neurotransmission in Bipolar Depression Following Treatment with Riluzole

Year: 2009

Type: article

Study design: Clinical Trial

Source: Neuropsychopharmacology

DOI: 10.1038/npp.2009.191

Authors: Brian P Brennan, James I Hudson, J Eric Jensen, Julie McCarthy, Jacqueline L Roberts, Andrew P Prescot, Bruce M Cohen, Harrison G Pope, Perry F Renshaw, Dost Öngür

Institutions: McLean Hospital, Harvard University, University of Utah

Language: English

Topic: Bipolar Disorder and Treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Eli Lilly and Company, Pfizer, GlaxoSmithKline, Sanofi, National Alliance for Research on Schizophrenia and Depression, Janssen Scientific Affairs, National Institute of Mental Health

Awards: G4735630354, MRS Studies of Glutamate and GABA in Bipolar Dissorder

OpenAlex ID: W2019754485

FWCI: 6.64

Cites: 68

Cited by: 168

Related to: 10